abrdn U.S. Small Cap Equity Fund Institutional Class GSCIX

Morningstar Medalist Rating
  • NAV / 1-Day Return $51.02  /  −0.62 %
  • Fund Size $373.4M
  • Adjusted Expense Ratio 0.950%
  • Net Expense Ratio 0.960%
  • Fee Level: Distribution Average
  • Share Class Type Institutional
  • Morningstar Category Small Blend
  • Equity Style Box (Funds) Small Growth
  • Minimum Initial Investment $1M
  • Investment Status Open
  • TTM Yield 0.00%
  • Turnover Ratio 48%

Morningstar’s Analysis GSCIX

Will GSCIX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

abrdn US Small Cap Equity Inst holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GSCIX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 26.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Ligand Pharmaceuticals Inc

2.89 10M
Healthcare

Q2 Holdings Inc

2.80 10M
Technology

Kiniksa Pharmaceuticals International PLC Class A

2.80 10M
Healthcare

Magnolia Oil & Gas Corp Class A

2.78 10M
Energy

Wintrust Financial Corp

2.68 10M
Financial Services

ANI Pharmaceuticals Inc

2.67 10M
Healthcare

WSFS Financial Corp

2.51 9M
Financial Services

Seacoast Banking Corp of Florida

2.48 9M
Financial Services

Supernus Pharmaceuticals Inc

2.48 9M
Healthcare

Ameris Bancorp

2.39 9M
Financial Services

Sponsor Center